{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:10:28Z","timestamp":1790201428362,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metal-induced hypersensitivity is driven by T-cell sensitization to metal ions. Although numerous metals are associated with the development of diffuse parenchymal lung disease, beryllium-induced hypersensitivity is the best-studied to date. This review focuses on the interaction between innate and adaptive immunity that leads to the development of chronic beryllium disease. After beryllium exposure, activation of the innate immune system occurs through the engagement of pattern-recognition receptors. This activation leads to cell death, release of alarmins, and activation and migration of dendritic cells to lung-draining lymph nodes. These events culminate in the development of an adaptive immune response that is characterized by beryllium-specific, T-helper type 1\u2013polarized, CD4+ T-cells and granuloma formation in the lung. The unique ability of beryllium to bind to human leukocyte antigen\u2013DP molecules that express a glutamic acid at position 69 of the \u03b2-chain alters the charge and conformation of the human leukocyte antigen\u2013DP\u2013peptide complex. These changes induce post-translational modifications that are recognized as non-self. In essence, the ability of beryllium to create neoantigens underlies the genesis of chronic beryllium disease, and demonstrates the similarity between beryllium-induced hypersensitivity and autoimmunity.<\/jats:p>","DOI":"10.1513\/annalsats.201707-573mg","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T09:45:03Z","timestamp":1524217503000},"page":"S81-S85","source":"Crossref","is-referenced-by-count":28,"title":["Immunologic Effects of Beryllium Exposure"],"prefix":"10.1093","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4095-512X","authenticated-orcid":false,"given":"Andrew P.","family":"Fontenot","sequence":"first","affiliation":[{"name":"Department of Medicine and Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,1]]},"reference":[{"key":"2026020502232505900_bib1","doi-asserted-by":"crossref","first-page":"pii: E66","DOI":"10.3390\/ijms17010066","article-title":"The metals in the biological periodic system of the elements: concepts and conjectures","volume":"17","author":"Maret","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2026020502232505900_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.coi.2016.05.001","article-title":"Interplay of innate and adaptive immunity in metal-induced hypersensitivity","volume":"42","author":"McKee","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"2026020502232505900_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2014.04.048","article-title":"Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity","volume":"158","author":"Clayton","year":"2014","journal-title":"Cell"},{"key":"2026020502232505900_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4049\/jimmunol.1502011","article-title":"Beryllium-induced hypersensitivity: genetic susceptibility and neoantigen generation","volume":"196","author":"Fontenot","year":"2016","journal-title":"J Immunol"},{"key":"2026020502232505900_bib5","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.4049\/jimmunol.171.12.6910","article-title":"Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease","volume":"171","author":"Maier","year":"2003","journal-title":"J Immunol"},{"key":"2026020502232505900_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajim.20045","article-title":"The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization","volume":"46","author":"McCanlies","year":"2004","journal-title":"Am J Ind Med"},{"key":"2026020502232505900_bib7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.8105536","article-title":"HLA-DPB1 glutamate 69: a genetic marker of beryllium disease","volume":"262","author":"Richeldi","year":"1993","journal-title":"Science"},{"key":"2026020502232505900_bib8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/ajrccm.165.6.2104002","article-title":"Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity","volume":"165","author":"Rossman","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502232505900_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1183\/09031936.01.00106201","article-title":"Major histocompatibility locus genetic markers of beryllium sensitization and disease","volume":"18","author":"Saltini","year":"2001","journal-title":"Eur Respir J"},{"key":"2026020502232505900_bib10","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.163.3.1647","article-title":"Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles","volume":"163","author":"Wang","year":"1999","journal-title":"J Immunol"},{"key":"2026020502232505900_bib11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0020-7519(92)90058-S","article-title":"The effect of adjuvant and specific or non-specific vaccination on development of protective immunity of rabbits against Trichostrongylus colubriformis infection","volume":"22","author":"Wedrychowicz","year":"1992","journal-title":"Int J Parasitol"},{"key":"2026020502232505900_bib12","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1128\/IAI.68.7.4032-4039.2000","article-title":"Beryllium, an adjuvant that promotes gamma interferon production","volume":"68","author":"Lee","year":"2000","journal-title":"Infect Immun"},{"key":"2026020502232505900_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tox.2005.10.016","article-title":"Chemokine regulation in response to beryllium exposure in human peripheral blood mononuclear and dendritic cells","volume":"218","author":"Hong-Geller","year":"2006","journal-title":"Toxicology"},{"key":"2026020502232505900_bib14","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1183\/09031936.02.02232001","article-title":"HLA-DP\u2013unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells","volume":"20","author":"Amicosante","year":"2002","journal-title":"Eur Respir J"},{"key":"2026020502232505900_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0300-483X(99)00182-1","article-title":"Beryllium-stimulated production of tumor necrosis factor-alpha by a mouse hybrid macrophage cell line","volume":"143","author":"Sawyer","year":"2000","journal-title":"Toxicology"},{"key":"2026020502232505900_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/00039896.1996.9935990","article-title":"Tumor necrosis factor alpha gene expression in human monocytic THP-1 cells exposed to beryllium","volume":"51","author":"Galbraith","year":"1996","journal-title":"Arch Environ Health"},{"key":"2026020502232505900_bib17","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.freeradbiomed.2004.12.014","article-title":"Beryllium-stimulated reactive oxygen species and macrophage apoptosis","volume":"38","author":"Sawyer","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"2026020502232505900_bib18","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.humimm.2014.10.010","article-title":"p38 mitogen-activated protein kinase in beryllium-induced dendritic cell activation","volume":"75","author":"Li","year":"2014","journal-title":"Hum Immunol"},{"key":"2026020502232505900_bib19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/mi.2015.14","article-title":"MyD88 dependence of beryllium-induced dendritic cell trafficking and CD4+ T-cell priming","volume":"8","author":"McKee","year":"2015","journal-title":"Mucosal Immunol"},{"key":"2026020502232505900_bib20","first-page":"101","article-title":"Beryllium induces apoptosis in human lung macrophages","volume":"19","author":"Kittle","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026020502232505900_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0300-483X(00)00237-7","article-title":"Beryllium-stimulated apoptosis in macrophage cell lines","volume":"149","author":"Sawyer","year":"2000","journal-title":"Toxicology"},{"key":"2026020502232505900_bib22","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.4049\/jimmunol.163.5.2592","article-title":"Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells","volume":"163","author":"Tsitoura","year":"1999","journal-title":"J Immunol"},{"key":"2026020502232505900_bib23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/j.1460-2075.1991.tb07648.x","article-title":"Selective interaction of Ni with an MHC-bound peptide","volume":"10","author":"Romagnoli","year":"1991","journal-title":"EMBO J"},{"key":"2026020502232505900_bib24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1084\/jem.20021762","article-title":"Components of the ligand for a Ni++ reactive human T cell clone","volume":"197","author":"Lu","year":"2003","journal-title":"J Exp Med"},{"key":"2026020502232505900_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1021\/bi00778a003","article-title":"Fluorescein: hapten and antibody active-site probe","volume":"10","author":"Lopatin","year":"1971","journal-title":"Biochemistry"},{"key":"2026020502232505900_bib26","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<1941::AID-IMMU1941>3.0.CO;2-H","article-title":"T cell cross-reactivity to heavy metals: identical cryptic peptides may be presented from protein exposed to different metals","volume":"28","author":"Griem","year":"1998","journal-title":"Eur J Immunol"},{"key":"2026020502232505900_bib27","doi-asserted-by":"crossref","first-page":"12717","DOI":"10.1073\/pnas.220430797","article-title":"Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease","volume":"97","author":"Fontenot","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020502232505900_bib28","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.166.5.3549","article-title":"HLA-DP allele\u2013specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease","volume":"166","author":"Lombardi","year":"2001","journal-title":"J Immunol"},{"key":"2026020502232505900_bib29","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1073\/pnas.1001772107","article-title":"Crystal structure of HLA-DP2 and implications for chronic beryllium disease","volume":"107","author":"Dai","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020502232505900_bib30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.20122426","article-title":"Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease","volume":"210","author":"Falta","year":"2013","journal-title":"J Exp Med"},{"key":"2026020502232505900_bib31","doi-asserted-by":"crossref","first-page":"8553","DOI":"10.1073\/pnas.1408048111","article-title":"Regulatory T cells modulate granulomatous inflammation in an HLA-DP2 transgenic murine model of beryllium-induced disease","volume":"111","author":"Mack","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020502232505900_bib32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"2026020502232505900_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.coi.2012.10.002","article-title":"Human leukocyte antigen\u2013associated drug hypersensitivity","volume":"25","author":"Illing","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"2026020502232505900_bib34","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4049\/jimmunol.163.2.1019","article-title":"Identification of pathogenic T cells in patients with beryllium-induced lung disease","volume":"163","author":"Fontenot","year":"1999","journal-title":"J Immunol"},{"key":"2026020502232505900_bib35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1165\/ajrcmb.18.4.2981","article-title":"Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease","volume":"18","author":"Fontenot","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020502232505900_bib36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-108-5-687","article-title":"Proliferative response of bronchoalveolar lymphocytes to beryllium: a test for chronic beryllium disease","volume":"108","author":"Rossman","year":"1988","journal-title":"Ann Intern Med"},{"key":"2026020502232505900_bib37","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1084\/jem.171.4.1123","article-title":"Biased accumulation of T lymphocytes with \u201cmemory\u201d-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung","volume":"171","author":"Saltini","year":"1990","journal-title":"J Exp Med"},{"key":"2026020502232505900_bib38","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJM198904273201702","article-title":"Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells","volume":"320","author":"Saltini","year":"1989","journal-title":"N Engl J Med"},{"key":"2026020502232505900_bib39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4049\/jimmunol.158.1.518","article-title":"Beryllium induces IL-2 and IFN-\u03b3 in berylliosis","volume":"158","author":"Tinkle","year":"1997","journal-title":"J Immunol"},{"key":"2026020502232505900_bib40","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI0215846","article-title":"Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease","volume":"110","author":"Fontenot","year":"2002","journal-title":"J Clin Invest"},{"key":"2026020502232505900_bib41","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1172\/JCI24908","article-title":"Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response","volume":"115","author":"Fontenot","year":"2005","journal-title":"J Clin Invest"},{"key":"2026020502232505900_bib42","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1172\/JCI200318317","article-title":"CD28 costimulation independence of target organ versus circulating memory antigen\u2013specific CD4+ T cells","volume":"112","author":"Fontenot","year":"2003","journal-title":"J Clin Invest"},{"key":"2026020502232505900_bib43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jaci.2007.03.009","article-title":"CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease","volume":"120","author":"Palmer","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2026020502232505900_bib44","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.4049\/jimmunol.180.4.2704","article-title":"Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease","volume":"180","author":"Palmer","year":"2008","journal-title":"J Immunol"},{"key":"2026020502232505900_bib45","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.4049\/jimmunol.1300282","article-title":"Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation","volume":"191","author":"Chain","year":"2013","journal-title":"J Immunol"},{"key":"2026020502232505900_bib46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7-CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2026020502232505900_bib47","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ajim.20736","article-title":"Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease","volume":"52","author":"Mroz","year":"2009","journal-title":"Am J Ind Med"},{"key":"2026020502232505900_bib48","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jaci.2011.08.022","article-title":"Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression","volume":"128","author":"Martin","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2026020502232505900_bib49","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2005.01.019","article-title":"Frequency of beryllium-specific, Th1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease","volume":"115","author":"Pott","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"2026020502232505900_bib50","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.4049\/jimmunol.1400007","article-title":"Identification of multiple public TCR repertoires in chronic beryllium disease","volume":"192","author":"Bowerman","year":"2014","journal-title":"J Immunol"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/15\/Supplement_2\/S81\/66734753\/annalsats_15_supplement_2_s81.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/15\/Supplement_2\/S81\/66734753\/annalsats_15_supplement_2_s81.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:23:37Z","timestamp":1770276217000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/15\/Supplement_2\/S81\/8457097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":50,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2018,4,1]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201707-573mg","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,4,1]]}}}